You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 September 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B), which focuses on brain health, said on Friday it has received US Food and Drug Administration orphan drug designation for asedebart (Lu AG13909), its investigational ...
11 September 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Friday that it has filed a bid to acquire the business operations and assets of IntegraGen, a company specialising in genomic analysis of n...
11 September 2026 - ABEC, a provider of customised solutions and services for biopharmaceutical manufacturing, on Thursday announced the grand opening of its newest manufacturing facility in Wilson, North Carolina.An official ribbon-cutting ceremony ...
10 September 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has granted Priority Review to its supplemental application for Enspryng (...
Seismic Pharmaceuticals enrols first patient in istaroxime global Phase 3 trial in cardiogenic shock
10 September 2026 - Seismic Pharmaceuticals, a biotechnology company focused on advancing novel treatments for heart failure, announced on Wednesday the enrolment of the first patient in its global Phase 3 clinical trial evaluating istaroxime in pati...
10 September 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Wednesday that it has dosed the first patient with rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial at Peki...
9 September 2026 - Biotechnology company Tyra Biosciences Inc (Nasdaq: TYRA) reported on Wednesday that its initial Phase 2 SURF302 results for oral dabogratinib in patients with FGFR3-altered low-grade intermediate-risk non-muscle invasive bladder c...